Commercial real estate instant insights for powerful business research, trends, and extensive education and information on CRE markets, practices, industries and sectors
Become a GlobeSt influencer! Learn about our latest recognition opportunities highlighting the individuals, firms and teams changing the commercial real estate landscape.
BRANCHBURG, NJ-The 15-building project will include a mix of pure office buildings, medical facilities and a day-care center. The first six buildings will be ready early next year.
NEWARK-The Public Service Enterprise Group subsidiary plans to build or expand several power plants in the Garden State, grow its Northeast grid, and phase out several obsolete plants.
MORRISTOWN, NJ-The 2-cent per $100 of assessed value increase would raise $10 million a year, with the proceeds going for the acquisition and preservation of open space in this Northern New Jersey county.
ATLANTIC CITY-It is costing $330 million and is opening three months late, but the tunnel portion of this city's Boardwalk-to-Marina Connector makes its debut today with much hoopla.
SECAUCUS, NJ-The developer wants to build a shopping center on a 35-acre Meadowlands site, but needs an access road through property owned by Hartz, which may have retail plans of its own.
JERSEY CITY-The financial services company will move its asset management division out of Manhattan, picking Harborside Financial Center over SL Green's Times Square area building.
PERTH AMBOY, NJ-Differences over payments and the project's schedule have been ironed out, so the developer will proceed with its $600-million mixed-use project.
EAST HANOVER, NJ-Market Measures Interactive is moving to the Eagle Rock complex from its existing space in Livingston, NJ in an expansion move. Part of new location's appeal is that MMI will have all it operations on one floor.
EATONTOWN, NJ-The 265,000-sf store at Monmouth Mall will be the largest for the venerable Pennsylvania-based chain, which is the country's largest privately owned department store operation.
NORTH BRUNSWICK, NJ-The pharmaceuticals giant will move ahead with its new two-building R&D complex here, with its price tag now set at $235 million.